Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial
- PMID: 26320890
- PMCID: PMC4573272
- DOI: 10.1016/j.jash.2015.06.012
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial
Abstract
The Systolic Blood Pressure Intervention Trial (SPRINT) will compare treatment to a systolic blood pressure goal of <120 mm Hg to treatment to the currently recommended goal of <140 mm Hg for effects on incident cardiovascular, renal, and neurologic outcomes including cognitive decline. The objectives of this analysis are to compare baseline characteristics of African American (AA) and non-AA SPRINT participants and explore factors associated with uncontrolled blood pressure (BP) by race. SPRINT enrolled 9361 hypertensive participants aged older than 50 years. This cross-sectional analysis examines sociodemographics, baseline characteristics, and study measures among AAs compared with non-AAs. AAs made up 31% of participants. AAs (compared with non-AAs) were younger and less frequently male, had less education, and were more likely uninsured or covered by Medicaid. In addition, AAs scored lower on the cognitive screening test when compared with non-AAs. Multivariate logistic regression analysis found BP control rates to <140/90 mm Hg were higher for AAs who were male, had higher number of chronic diseases, were on diuretic treatment, and had better medication adherence. SPRINT is well poised to examine the effects of systolic blood pressure targets on clinical outcomes as well as predictors influencing BP control in AAs.
Keywords: Cardiovascular disease; SPRINT; blacks; clinical trials; hypertension.
Copyright © 2015 American Society of Hypertension. All rights reserved.
Conflict of interest statement
Conflict of Interest: We have no conflicts of interest to disclose.
Comment in
-
Is there a bend in the upward trend of high blood pressure in childhood?: A commentary on prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012.J Am Soc Hypertens. 2015 Sep;9(9):668-9. doi: 10.1016/j.jash.2015.07.003. Epub 2015 Jul 14. J Am Soc Hypertens. 2015. PMID: 26260425 No abstract available.
-
From the Editor.J Am Soc Hypertens. 2015 Sep;9(9):661-2. doi: 10.1016/j.jash.2015.07.017. Epub 2015 Jul 31. J Am Soc Hypertens. 2015. PMID: 26369440 No abstract available.
References
-
- Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;133:1–8. - PubMed
-
- Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol. 2011 May 17;57(20):2037–114. doi: 10.1016/j.jacc.2011.01.008. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1TR000433/TR/NCATS NIH HHS/United States
- UL1RR025752/RR/NCRR NIH HHS/United States
- UL1 TR000093/TR/NCATS NIH HHS/United States
- UL1TR000005/TR/NCATS NIH HHS/United States
- UL1 TR000050/TR/NCATS NIH HHS/United States
- UL1 RR025755/RR/NCRR NIH HHS/United States
- UL1 TR001085/TR/NCATS NIH HHS/United States
- UL1TR000439/TR/NCATS NIH HHS/United States
- UL1TR000064/TR/NCATS NIH HHS/United States
- UL1TR000075/TR/NCATS NIH HHS/United States
- UL1 RR024134/RR/NCRR NIH HHS/United States
- UL1 TR000433/TR/NCATS NIH HHS/United States
- UL1TR000050/TR/NCATS NIH HHS/United States
- 9U54TR000017-06/TR/NCATS NIH HHS/United States
- UL1 TR000445/TR/NCATS NIH HHS/United States
- HHSN268200900048C/HL/NHLBI NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- UL1TR000445/TR/NCATS NIH HHS/United States
- HHSN268200900040C/HL/NHLBI NIH HHS/United States
- UL1TR000093/TR/NCATS NIH HHS/United States
- HHSN268200900046C/HL/NHLBI NIH HHS/United States
- UL1 TR000064/TR/NCATS NIH HHS/United States
- UL1TR000002/TR/NCATS NIH HHS/United States
- UL1TR000073/TR/NCATS NIH HHS/United States
- R01 HL104199/HL/NHLBI NIH HHS/United States
- UL1RR025755/RR/NCRR NIH HHS/United States
- UL1 TR000075/TR/NCATS NIH HHS/United States
- UL1RR025771/RR/NCRR NIH HHS/United States
- UL1 TR001064/TR/NCATS NIH HHS/United States
- UL1 RR025752/RR/NCRR NIH HHS/United States
- UL1TR000105-05/TR/NCATS NIH HHS/United States
- UL1 RR025771/RR/NCRR NIH HHS/United States
- HHSN268200900049C/HL/NHLBI NIH HHS/United States
- HHSN268200900047C/HL/NHLBI NIH HHS/United States
- UL1 TR001427/TR/NCATS NIH HHS/United States
- UL1 TR000003/TR/NCATS NIH HHS/United States
- UL1TR000003/TR/NCATS NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- UL1 TR000073/TR/NCATS NIH HHS/United States
- UL1 TR000002/TR/NCATS NIH HHS/United States
- UL1 TR000105/TR/NCATS NIH HHS/United States
- UL1TR001064/TR/NCATS NIH HHS/United States
- UL1RR024134/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
